Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Hosp Infect ; 53(3): 229-31, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12623326

RESUMEN

We investigated the effects of inhalation of tea catechin on MRSA in the 24 elderly in patients, who were known to carry MRSA in sputum. The patients in the catechin group (N=12) were administered an inhalation of tea catechin extracts (in saline/bromhexine) (3.7 g/L catechins, 43% of them are composed of epigallocatechin gallate), three times daily with hand nebulizer for four weeks. The clinical effects were compared with the control group (N=12) who were given an inhalation of saline/bromhexine alone. After a week of the course, the numbers of the patients with decreased or disappearance of MRSA in their sputum was significantly higher in the catechin group, compared with that in the control group (seven vs. no patients; P<0.05). The number of patients discharged during the study was significantly increased, and the days of hospital stay were significantly decreased in the catechin group compared with those in the control group (six vs. one patient; P<0.05, 51+/-22 vs. 85+/-50 days, mean+/-S.D.;P <0.05, respectively). No adverse effects were observed in any patients during the study. Catechin inhalation seemed to be safe, and at least temporarily effective in the reduction of MRSA and shortening of hospitalization.


Asunto(s)
Portador Sano/tratamiento farmacológico , Catequina/administración & dosificación , Infección Hospitalaria/tratamiento farmacológico , Resistencia a la Meticilina , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus , , Actividades Cotidianas , Administración por Inhalación , Anciano , Anciano de 80 o más Años , Portador Sano/microbiología , Infección Hospitalaria/microbiología , Femenino , Evaluación Geriátrica , Unidades Hospitalarias , Humanos , Japón , Tiempo de Internación/estadística & datos numéricos , Masculino , Esputo/microbiología , Infecciones Estafilocócicas/microbiología , Factores de Tiempo , Resultado del Tratamiento
2.
Chem Pharm Bull (Tokyo) ; 42(8): 1669-71, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7954920

RESUMEN

A new phenolic glycoside, 3,4,5-trimethoxyphenol-1-(6-xylopyranosyl)glucopyranoside, was isolated together with twenty known compounds identified as koaburaside, 3,4,5-trimethoxyphenol, 5,7-dihydroxychromone-7-neohesperidoside, naringin, neoeriocitrin, p-coumaric acid, vanillin, vanillic acid, coniferyl aldehyde, ferulic acid, trans-triacontyl-4-hydroxy-3-methoxycinnamate, p-methoxycinnamic acid, 2,6-dimethoxybenzoquinone, 2-(1-hydroxyethyl)naphtho[2,3-b]furan-4,9-dione, 2-acetylnaphtho[2,3-b]furan-4,9-dione, 2-(1-hydroxyethyl)-6-methoxynaphtho[2,3-b]furan-4,9-dione, 2-acetyl-6-methoxynaphtho[2,3-b]furan-4,9-dione, specioside, jioglutin C and rehmaglutin D from the bark of Ailanthus integrifolia Lamk (Simaroubaceae).


Asunto(s)
Glicósidos/aislamiento & purificación , Extractos Vegetales/química , Glicósidos/química , Indonesia , Espectroscopía de Resonancia Magnética , Plantas Medicinales , Espectrofotometría Ultravioleta , Árboles
3.
Lancet ; 2(8668): 886-8, 1989 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-2571814

RESUMEN

To investigate the failure of vaccines to prevent mother-to-infant transmission of hepatitis B virus (HBV), serum, cord blood, and colostrum samples from eleven mothers, known to be carriers of hepatitis B surface antigen, and their infants were examined by means of a highly sensitive polymerase chain reaction (PCR) method. HBV-specific DNA was detected in ten maternal serum samples, eight samples of colostral whey, eight samples of colostral cells, and one cord blood sample. Four infants of mothers with HBV-DNA-positive colostrum showed low responsiveness to hepatitis B vaccine. The infant whose cord blood was positive for HBV DNA showed low responsiveness to hepatitis B vaccine and subsequently became an HBV carrier. These results suggest the need for further study to evaluate whether breastfeeding is advisable for HBV carriers.


Asunto(s)
Portador Sano/microbiología , ADN Viral/análisis , Virus de la Hepatitis B/genética , Hepatitis B/transmisión , Vacunas contra Hepatitis Viral/administración & dosificación , Portador Sano/inmunología , Calostro/microbiología , ADN Polimerasa Dirigida por ADN , Estudios de Evaluación como Asunto , Sangre Fetal/microbiología , Pruebas de Hemaglutinación , Hepatitis B/prevención & control , Vacunas contra Hepatitis B , Humanos , Esquemas de Inmunización , Lactante , Hibridación de Ácido Nucleico , Sondas de Oligonucleótidos , Reacción en Cadena de la Polimerasa/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA